152 related articles for article (PubMed ID: 10627666)
1. Allogeneic bone marrow transplantation for paroxysmal nocturnal hemoglobinuria.
Araten DJ; Luzzatto L
Haematologica; 2000 Jan; 85(1):1-2. PubMed ID: 10627666
[No Abstract] [Full Text] [Related]
2. Recovery from CMV esophagitis after allogeneic bone marrow transplantation using non-myeloablative conditioning: the role of immunosuppression.
Fiegl M; Gerbitz A; Gaeta A; Campe H; Jaeger G; Kolb HJ
J Clin Virol; 2005 Nov; 34(3):219-23. PubMed ID: 16129661
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria.
Raiola AM; Van Lint MT; Lamparelli T; Gualandi F; Benvenuto F; Figari O; Mordini N; Berisso G; Bregante S; Frassoni F; Bacigalupo A
Haematologica; 2000 Jan; 85(1):59-62. PubMed ID: 10629593
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
[TBL] [Abstract][Full Text] [Related]
5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
6. Chronic graft-versus-host disease following allogeneic peripheral blood and bone marrow stem cell transplants: a single center experience.
Takami A; Ishiyama K; Asakura H; Shiobara S; Nakao S
Haematologica; 2002 Jun; 87(6):664-6. PubMed ID: 12031928
[No Abstract] [Full Text] [Related]
7. Unrelated donor bone marrow transplantation with treosulfan-based myeloablative conditioning for paroxysmal nocturnal hemoglobinuria--successful treatment despite multiple transplant-related risk factors for hemolysis including major Kidd group incompatibility.
Markiewicz M; Wojciechowska M; Wylezoł I; Woźniczka K; Giebel S; Wojnar J; Krawczyk-Kuliś M; Mendek-Czajkowska E; Hołowiecki J
Bone Marrow Transplant; 2006 Jan; 37(2):231-2. PubMed ID: 16247413
[No Abstract] [Full Text] [Related]
8. Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation.
Schulenburg A; Turetschek K; Wrba F; Vogelsang H; Greinix HT; Keil F; Mitterbauer M; Kalhs P
Ann Hematol; 2004 Feb; 83(2):101-6. PubMed ID: 14615909
[TBL] [Abstract][Full Text] [Related]
9. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
[TBL] [Abstract][Full Text] [Related]
10. Impact of discontinuing fluoroquinolone prophylaxis on early mortality after allogeneic marrow or peripheral blood SCT with myeloablative conditioning.
Kanda J; Ichinohe T; Saito T; Yamashita K; Kondo T; Ishikawa T; Ichiyama S; Uchiyama T
Bone Marrow Transplant; 2010 Aug; 45(8):1369-71. PubMed ID: 19966848
[No Abstract] [Full Text] [Related]
11. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
Prigozhina TB; Elkin G; Khitrin S; Slavin S
Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic bone marrow transplantation for Pearson's syndrome.
Faraci M; Cuzzubbo D; Micalizzi C; Lanino E; Morreale G; Dallorso S; Castagnola E; Schiaffino MC; Bruno C; Rossi A; Dini G; Cappelli B
Bone Marrow Transplant; 2007 May; 39(9):563-5. PubMed ID: 17334378
[No Abstract] [Full Text] [Related]
13. Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients.
Iravani M; Evazi MR; Mousavi SA; Shamshiri AR; Tavakoli M; Ashouri A; Samiee S; Chahardovali B; Alimoghaddam K; Ghaffari SH; Ghavamzadeh A
Bone Marrow Transplant; 2007 Jul; 40(2):105-10. PubMed ID: 17468775
[TBL] [Abstract][Full Text] [Related]
14. Late marrow allograft rejection following alpha-interferon therapy for hepatitis in a patient with paroxysmal nocturnal hemoglobinuria.
de Souza MH; Abdelhay E; Silva ML; Diamond HR; Valente AN; Tabak DG; Bouzas LF; Ribeiro RC
Bone Marrow Transplant; 1992 Jun; 9(6):495-7. PubMed ID: 1628136
[TBL] [Abstract][Full Text] [Related]
15. Successful unrelated donor bone marrow transplantation for paroxysmal nocturnal hemoglobinuria.
Woodard P; Wang W; Pitts N; Benaim E; Horwitz E; Cunningham J; Bowman L
Bone Marrow Transplant; 2001 Mar; 27(6):589-92. PubMed ID: 11319587
[TBL] [Abstract][Full Text] [Related]
16. Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial.
Markova M; Barker JN; Miller JS; Arora M; Wagner JE; Burns LJ; MacMillan ML; Douek D; DeFor T; Tan Y; Repka T; Blazar BR; Weisdorf DJ
Bone Marrow Transplant; 2007 Feb; 39(4):193-9. PubMed ID: 17220905
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation for paroxysmal nocturnal haemoglobinuria.
Bemba M; Guardiola P; Garderet L; Devergie A; Ribaud P; Esperou H; Noguera MH; Gluckman E; Socié G
Br J Haematol; 1999 May; 105(2):366-8. PubMed ID: 10233405
[TBL] [Abstract][Full Text] [Related]
18. [Allogenic bone marrow transplantation complications. Part II].
Saloua L; Tarek BO; Abderrahman A; Abdeladhim BA
Tunis Med; 2000 Mar; 78(3):152-7. PubMed ID: 11026816
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: a single centre experience and review of the literature.
Matthes-Martin S; Mann G; Peters C; Lion T; Fritsch G; Haas OA; Pötschger U; Gadner H
Bone Marrow Transplant; 2000 Aug; 26(4):377-82. PubMed ID: 10982283
[TBL] [Abstract][Full Text] [Related]
20. Letter: Therapy for paroxysmal nocturnal hemoglobinuria.
Freeman H
N Engl J Med; 1973 Dec; 289(23):1253-4. PubMed ID: 4583989
[No Abstract] [Full Text] [Related]
[Next] [New Search]
